Role of TNFα in Pulmonary Diseases
Author Information
Author(s): Srirupa Mukhopadhyay, John R Hoidal, Tapan K Mukherjee
Primary Institution: University of Utah Health Science Center
Hypothesis
High levels of TNFα are implicated in the pathophysiology of various pulmonary diseases.
Conclusion
Anti-TNFα therapies show varying levels of success in treating pulmonary diseases, but conclusive efficacy data is still lacking.
Supporting Evidence
- High levels of TNFα are linked to asthma, chronic bronchitis, and COPD.
- TNFα can deplete cellular antioxidants, leading to increased oxidative stress.
- Anti-TNFα therapies have shown varying success in treating inflammatory lung diseases.
Takeaway
TNFα is a protein that can cause inflammation in the lungs, and scientists are studying ways to block it to help people with lung diseases.
Potential Biases
Potential biases in the interpretation of TNFα's role due to varying responses in different populations.
Limitations
The review does not provide conclusive data on the efficacy of anti-TNFα therapy for major pulmonary diseases.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website